Chase Oswald | Investor Relations, LifeSci Advisors |
Dave Domzalski | President & Chief Executive Officer |
Tyler Zeronda | Chief Financial Officer |
Iain Stuart | Chief Scientific Officer |
Mutya Harsch | General Counsel & Chief Legal Officer |
Carvey Leung | Cantor Fitzgerald |
Ken Cacciatore | Cowen |
David Amsellem | Piper Sandler |
Patrick Dolezal | LifeSci Capital |
Oren Livnat | H.C. Wainwright |
Balaji Prasad | Barclays |
Greetings and welcome to the VYNE Therapeutics Second Quarter 2021 Earnings Call.
During the presentation, all participants will be in a listen-only mode. Afterwards, we will conduct a question-and-answer session. [Operator Instructions] As a reminder, this conference is being recorded Thursday, August 12, 2021. I would now like to turn the conference over to Chase Oswald from LifeSci Advisors.